Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans

Author:

Peluso A. AugustoORCID,Lundgaard Agnete T.,Babaei Parizad,Mousovich-Neto Felippe,Rocha Andréa L.,Damgaard Mads V.,Bak Emilie G.,Gnanasekaran Thiyagarajan,Dollerup Ole L.,Trammell Samuel A. J.,Nielsen Thomas S.ORCID,Kern TimoORCID,Abild Caroline B.,Sulek Karolina,Ma TaoORCID,Gerhart-Hines Zach,Gillum Matthew P.,Arumugam Manimozhiyan,Ørskov Cathrine,McCloskey Douglas,Jessen Niels,Herrgård Markus J.,Mori Marcelo A. S.,Treebak Jonas T.ORCID

Abstract

AbstractThe gut microbiota impacts systemic levels of multiple metabolites including NAD+precursors through diverse pathways. Nicotinamide riboside (NR) is an NAD+precursor capable of regulating mammalian cellular metabolism. Some bacterial families express the NR-specific transporter,PnuC. We hypothesized that dietary NR supplementation would modify the gut microbiota across intestinal sections. We determined the effects of 12 weeks of NR supplementation on the microbiota composition of intestinal segments of high-fat diet-fed (HFD) rats. We also explored the effects of 12 weeks of NR supplementation on the gut microbiota in humans and mice. In rats, NR reduced fat mass and tended to decrease body weight. Interestingly, NR increased fat and energy absorption but only in HFD-fed rats. Moreover, 16S rRNA gene sequencing analysis of intestinal and fecal samples revealed an increased abundance of species withinErysipelotrichaceaeandRuminococcaceaefamilies in response to NR.PnuC-positive bacterial strains within these families showed an increased growth rate when supplemented with NR. The abundance of species within theLachnospiraceaefamily decreased in response to HFD irrespective of NR. Alpha and beta diversity and bacterial composition of the human fecal microbiota were unaltered by NR, but in mice, the fecal abundance of species withinLachnospiraceaeincreased while abundances ofParasutterellaandBacteroides doreispecies decreased in response to NR. In conclusion, oral NR altered the gut microbiota in rats and mice, but not in humans. In addition, NR attenuated body fat mass gain in rats, and increased fat and energy absorption in the HFD context.

Funder

Novo Nordisk Fonden

Innovationsfonden

Novo Nordisk

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Springer Science and Business Media LLC

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3